Table of contents

Ovarian Cancer

• Significance of Serum Human Epididymis Protein 4 and Cancer Antigen 125 in Distinguishing Type I and Type II Epithelial Ovarian Cancers (1 June, 2018)

  Marut Yanaranop, Natcha Jantarateptewan, Jitima Tiyayon, Saranyu Nakrangsee
• The Clearance of Serum Human Epididymis Protein 4 Following Primary Cytoreductive Surgery for Ovarian Carcinoma (1 June, 2018)

  Claire Thompson, Waseem Kamran, Lucy Dockrell, Srwa Khalid, Meena Kumari, Nadia Ibrahim, John O'Leary, Lucy Norris, Max Petzold, Sharon O'Toole, Noreen Gleeson
• Incidental Thoracic Findings on Routine Computed Tomography in Epithelial Ovarian Cancer (1 June, 2018)

  Bobby D. O'Leary, Teresa Treacy, Tony Geoghegan, Tom A. Walsh, William D. Boyd, Donal J. Brennan
• Economic Analysis of Neoadjuvant Chemotherapy Versus Primary Debulking Surgery for Advanced Epithelial Ovarian Cancer Using an Aggressive Surgical Paradigm (1 June, 2018)

  Ashley L. Cole, Emma L. Barber, Anagha Gogate, Arthur-Quan Tran, Stephanie B. Wheeler
• Cyclooxygenase Inhibitors in Epithelial Ovarian Cancer Treatment (1 June, 2018)

  Xiangyang Zeng, Shuijing Yi
• Long-Term Survival After Surgery and Radiotherapy for Recurrent or Persistent Ovarian and Tubal Cancer (1 June, 2018)

  Robert Rome, Joanna Dipnall, Sam Leung
• Changing Clinical Practice: Evaluation of Implementing Recommendations for Opportunistic Salpingectomy in British Columbia and Ontario (1 June, 2018)

  Bryn Lander, Elizabeth Wilcox, Jessica N. McAlpine, Sarah J. Finlayson, David G. Huntsman, Dianne Miller, Gillian E. Hanley
• Prognostic Value of Serum CA19-9 and Perioperative CA-125 Levels in Ovarian Clear Cell Carcinoma (1 June, 2018)

  Jun Zhu, Long Jiang, Hao Wen, Rui Bi, Xiaohua Wu, Xingzhu Ju